These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays. Fabrizi F, Raffaele L, Bacchini G, Guarnori I, Pontoriero G, Erba G, Locatelli F. Nephrol Dial Transplant; 1993; 8(8):744-7. PubMed ID: 7692356 [Abstract] [Full Text] [Related]
4. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members]. Miyasaka M. Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830 [Abstract] [Full Text] [Related]
5. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients. Yamaguchi K, Kiyokawa H, Machida J, Obayashi A, Nojiri N, Ueda S, Takatsuki K. FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023 [Abstract] [Full Text] [Related]
7. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff. Fujiyama S, Kawano S, Sato S, Tanaka M, Goto M, Taura Y, Sato T, Kawahara T, Mizuno K. Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811 [Abstract] [Full Text] [Related]
9. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H. Ren Fail; 2006 Apr; 28(8):729-35. PubMed ID: 17162434 [Abstract] [Full Text] [Related]
10. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Chan TM, Lok AS, Cheng IK. Nephrol Dial Transplant; 1991 Apr; 6(12):944-7. PubMed ID: 1724691 [Abstract] [Full Text] [Related]
12. [Anti-HCV in patients without risk factors for hepatitis C. Prospective study in 200 patients]. Albornoz A, Esaa R, Rodríguez de Leon L, Mujica C. G E N; 1993 Apr; 47(3):136-8. PubMed ID: 7509301 [Abstract] [Full Text] [Related]
14. Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them. Blackmore TK, Stace NH, Maddocks P, Hatfield P. Aust N Z J Med; 1992 Aug; 22(4):353-7. PubMed ID: 1280095 [Abstract] [Full Text] [Related]
15. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients. Ayoola EA, Huraib S, Arif M, al-Faleh FZ, al-Rashed R, Ramia S, al-Mofleh IA, Abu-Aisha H. J Med Virol; 1991 Nov; 35(3):155-9. PubMed ID: 1725179 [Abstract] [Full Text] [Related]
18. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Conway M, Catterall AP, Brown EA, Tibbs C, Gower PE, Curtis JR, Coleman JC, Murray-Lyon IM. Nephrol Dial Transplant; 1992 Nov; 7(12):1226-9. PubMed ID: 1283447 [Abstract] [Full Text] [Related]
19. Prevalence of hepatitis C infection in a hemodialysis unit. Colombo P, Filiberti O, Porcu M, Costantini L, Mangione A, Monzeglio C, Peona C. Nephron; 1992 Nov; 61(3):326-7. PubMed ID: 1323782 [Abstract] [Full Text] [Related]